LQMC/CIBFar: “New mechanisms to accelerate drug discovery for Neglected Tropical Diseases (NTDs)”
The Drugs for Neglected Diseases initiative (DNDi) is a
patient-needs driven, not-for-profit research and development (R&D) organization that develops safe, effective, and affordable medicines for the millions of neglected patients across the world. DNDi focuses on developing new treatments for the most neglected patients suffering from diseases such as human African trypanosomiasis (sleeping sickness), leishmaniasis, Chagas disease, filariasis, paediatric HIV, mycetoma, and hepatitis C. The initiative’s primary objective is to deliver a total of 16 to 18 treatments by 2023 and to establish a strong R&D portfolio for these diseases. The R&D strategies developed by DNDi since its inception aim to address the immediate needs of patients by improving existing therapeutic options in the short term, whilst undertaking longer term research to identify and develop entirely new compounds which will be valuable adapted tools, particularly for elimination targets set by the World Health Organization. In 2013, DNDi began building a new consortium in Latin America (LOLA), providing support and mentoring for young scientists in the region. The consortia conduct hit-to-lead and lead optimization activities for visceral leishmaniasis and Chagas disease via a decentralized virtual model, and the talk focus will be the innovative R&D model and the efforts aiming at strengthening research capacities in the region. Jadel Kratz joined DNDi in June 2016 as Lead Optimization Latin America Coordinator focused in drug discovery projects in the region. He supports both the global and local R&D teams, and promotes the expansion of a regional consortia of scientific partners. Prior to joining DNDi, Dr. Kratz participated and coordinated academic research projects across various areas. Recently, he worked as R&D Coordinator at Cristália, a Brazilian-based pharmaceutical company. Dr Kratz is a pharmacist, and earned his PhD in Pharmaceutical Sciences (2011) at the Universidade Federal de Santa Catarina, Florianópolis, Brazil, with a visiting researcher period at the Uppsala University, Sweden. He completed postdoctoral fellowships at the University of Innsbruck and the University of Vienna, Austria.




As interpretações que lhe contaram de mecanica quântica são realmente as que saem dos experimentos? Ou mesmo as que saem dos postulados formais da teoria? Que argumentos descartaram a possibilidade de uma interpretação causal para a mecânica quântica na época em que a controversia ainda tinha lugar entre os principais pesquisadores da área, marginalizando todas as tentativas posteriores de formular descrições não probabilísticas (não causais) de processos quânticos? A mecânica bohmiana, resultado dos trabalho de David Bohm nos anos 50, é atualmente mencionada por físicos quase sempre como uma curiosidade histórica e não como uma alternativa teórica de fato, sendo subestimada e amplamente ignorada por esses. Nesse Filosofísica, o nosso queridíssimo filosofísico Iago Israel, vai nos explicar (bem do começo) o que a teoria de Bohm tem de diferente, interessante e como ela tenta contornar alguns aspectos problemáticos (para alguns) da interpretação usual, puramente probabilística.
Using the Lagrangian hydrodynamic approach [1] we derive the ideal hydrodynamic limit of a fluid with a net polarization of the microscopic degrees of freedom. We discuss the relevance of this dynamics in the light of the experimental study of Hadron (Lambda and vector meson) polarization and other spin-dependent observables in heavy ion collisions, and conclude that our approach is the first term in an effective theory expansion appropriate to study these phenomena quantitatively.
O desenvolvimento de um novo fármaco é um processo longo e pleno de desafios. Quanto mais informações se dispõem sobre o(s) mecanismo(s) de uma doença, maior é a probabilidade de encontrar uma terapia apropriada. Por outro lado, quanto melhor e mais cedo uma enfermidade puder ser diagnosticada, maiores são as chances de poder interferir no processo patológico com uma entidade química ou biológica. Esta premissa estabelece a base para o uso de técnicas de imagens no campo da farmacologia. A relevância dessas técnicas para a obtenção e quantificação de informação anatômica, funcional, metabólica ou molecular no contexto da pesquisa farmacológica in vivo será discutida e ilustrada através de exemplos oriundos de diferentes especialidades, da neurologia à oncologia.
We from IFSC OSA Student Chapter have the honour to receive Prof. Eric Van Stryland as part of the Travelling Lecturer program of the Optical Society. Prof. Stryland will give two seminars, a brief one about the history of The Optical Society and other pointing out fundamental aspects of his cutting-edge research. You are welcome to attend both seminars that will be held at Sala F-210 (Administration building) at 2 p.m of November 11th. Take a look below for further information about Prof. Stryland and the seminars.
Over the last two decades, there has been a strong interest in the cosmic ray positron fraction which exhibit an excess of high energy positrons whose origin is still highly uncertain. The Alpha Magnetic Spectrometer (AMS-02) is a general purpose high-energy particle physics detector operational on the International Space Station since May 2011. During its unique long duration mission AMS-02 is collecting large amount of data to study the behaviour of cosmic ray electrons and positrons with unprecedented precision. The latest measurements of positron fraction, positron flux and electron flux with AMS-02 will benpresented. The interpretation of the positron excess in terms of pulsar or dark matter will be presented in this talk.
rincipal começa a estudar as características dos raios X, recém-descobertos, e em 1903 divulga seus achados sobre uma nova radiação, os “raios N”. Essa descoberta fez sucesso, uma nova área da física nasceu, houve trabalhos aplicando os raios N ao estudo do sistema nervoso. Em 1905 a maioria dos físicos, incluindo revistas científicas, concluiu que essa radiação não existia.
Spectroscopic and microscopic techniques allow analysis of various aspects of biological systems on molecular level. One of the common problems of such studies is overlapping of absorption or fluorescence spectra of biological molecules of interest. Several examples of how to separate them are shown for in vitro and in vivo systems. These examples include analysis of competitive binding of two molecules (anticancer drugs, mutagens and biologically active substances) to nucleic acids via absorption spectroscopy, separation of fluorescence spectra of Photosystems via time-resolved fluorescence spectroscopy and microscopy and analysis of Forster Resonance Energy Transfer (FRET) between voltage-sensitive fluorescence proteins. As a result constants of binding of anticancer drugs and mutagens to nucleic acids are determined for molecules that absorb light in the same region with nucleic acids. Also composition and ratio of Photosystems is determined in leaves, which opens room for non-invasive “express” analysis of these parameters in plants, allowing determination of optimal growing conditions and presence of diseases. FRET studies of voltage sensitive fluorescent protein help to figure out the mechanism of its action and improve its functionality. In general, it is shown that number of different approaches can be used to analyze overlapping absorption and fluorescence spectra of biological molecules on different levels of organization in vitro and in vivo.
Research and development related to polymers from renewable resources have witnessed a spectacular development from the beginning of this millennium, with a progressively deeper and wider involvement of both academia and industry. This lecture aims at providing a succinct “state of the art” of this exciting field through a number of examples of recent advances, including contributions from my research groups. Two main approaches are discussed, namely: The chemical modification of natural polymers. This topic covers the synthesis and characterization of novel materials and composites arising from the surface, in-depth and bulk transformation of celulose fibers, including nanofibers, chitosan, starch, lignin and natural rubber. The synthesis and polymerization of monomers derived from renewable resources. The variety of such monomers and macromonomers has already reached a remarkably wide spectrum and is increasing incessantly. The examples provided in this context deal with small molecules derived from sugars and polysaccharides, lignin, and larger structures derived from vegetable oils. Particular emphasis is placed on furan monomers and furan chemistry, which provide a new class of polymer chemistry, including the application of structure-specific mechanisms like the Diels-Alder click reaction. Additionally, the peculiar properties of some of these new macromolecular materials, such as poly(lactic acid), other polyesters, polyamides and polyurethanes, are highlighted to show, among other features, their unique applications, e.g. recyclability and self-mendability.